Perrigo Company plc (PRGO) Financial Statements (2024 and earlier)
Company Profile
Business Address |
THE SHARP BUILDING DUBLIN 2, D02 TY74 |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 555 | 553 | 601 | 469 | 485 | 1,966 | |||
Cash and cash equivalents | 555 | 553 | 601 | 469 | 485 | 1,966 | |||
Receivables | 754 | 739 | 697 | 708 | 750 | 679 | |||
Inventory, net of allowances, customer advances and progress billings | 1,168 | 1,183 | 1,150 | 1,085 | 1,080 | 1,022 | |||
Inventory | 1,168 | 1,183 | 1,150 | 1,085 | 1,080 | 1,022 | |||
Other undisclosed current assets | 296 | 266 | 272 | 322 | 336 | 268 | |||
Total current assets: | 2,773 | 2,741 | 2,720 | 2,583 | 2,652 | 3,936 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 217 | ||||||||
Property, plant and equipment | 918 | 919 | 926 | 840 | 840 | 846 | |||
Deferred income tax assets | 6 | 6 | 7 | 8 | 7 | 7 | |||
Other noncurrent assets | 372 | 343 | 368 | 542 | 409 | 376 | |||
Other undisclosed noncurrent assets | 6,896 | 6,946 | 6,779 | 6,705 | 7,012 | 5,225 | |||
Total noncurrent assets: | 8,192 | 8,214 | 8,297 | 8,094 | 8,268 | 6,454 | |||
TOTAL ASSETS: | 10,965 | 10,955 | 11,017 | 10,678 | 10,920 | 10,390 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 732 | 777 | 788 | 844 | 840 | 844 | |||
Taxes payable | ✕ | ✕ | ✕ | ✕ | 22 | 5 | 5 | ||
Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 118 | 104 | 89 | ||
Accounts payable | 471 | 505 | 537 | 461 | 490 | 480 | |||
Accrued liabilities | 262 | 272 | 250 | 243 | 241 | 271 | |||
Debt | 38 | 39 | 36 | 34 | 31 | 5 | |||
Other undisclosed current liabilities | 286 | 271 | 290 | 137 | 144 | 132 | |||
Total current liabilities: | 1,057 | 1,087 | 1,114 | 1,015 | 1,015 | 981 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 4,056 | 4,063 | 4,070 | 4,078 | 4,086 | 3,511 | |||
Long-term debt, excluding current maturities | 4,056 | 4,063 | 4,070 | 4,078 | 4,086 | 3,511 | |||
Liabilities, other than long-term debt | 1,003 | 971 | 991 | 982 | 969 | 793 | |||
Deferred income tax liabilities | 345 | 334 | 368 | 409 | 392 | 239 | |||
Other liabilities | 659 | 638 | 623 | 573 | 577 | 554 | |||
Total noncurrent liabilities: | 5,059 | 5,034 | 5,062 | 5,060 | 5,055 | 4,304 | |||
Total liabilities: | 6,116 | 6,121 | 6,175 | 6,075 | 6,070 | 5,285 | |||
Equity | |||||||||
Equity, attributable to parent | 4,849 | 4,834 | 4,842 | 4,603 | 4,850 | 5,105 | |||
Common stock | 6,891 | 6,911 | 6,937 | 6,964 | 6,991 | 7,019 | |||
Accumulated other comprehensive income (loss) | 20 | (6) | (27) | (317) | (147) | 15 | |||
Accumulated deficit | (2,062) | (2,071) | (2,068) | (2,044) | (1,995) | (1,929) | |||
Total equity: | 4,849 | 4,834 | 4,842 | 4,603 | 4,850 | 5,105 | |||
TOTAL LIABILITIES AND EQUITY: | 10,965 | 10,955 | 11,017 | 10,678 | 10,920 | 10,390 |
Income Statement (P&L) ($ in millions)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 1,193 | 1,182 | 1,155 | 1,100 | 1,122 | 1,075 | ||
Cost of revenue (Cost of Goods and Services Sold) | (765) | (768) | (773) | (737) | (750) | (737) | ||
Gross profit: | 428 | 414 | 383 | 363 | 372 | 338 | ||
Operating expenses | (371) | (365) | (352) | (330) | (379) | (316) | ||
Operating income (loss): | 57 | 49 | 31 | 33 | (7) | 22 | ||
Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 10 | (1) | (4) | 4 | (54) | 1 | ||
Interest and debt expense | (0) | (0) | 0 | (9) | (0) | |||
Income (loss) from continuing operations before income taxes: | 66 | 48 | 27 | 38 | (70) | 23 | ||
Income tax expense (benefit) | (14) | (5) | 2 | (49) | 43 | 12 | ||
Income (loss) from continuing operations: | 53 | 43 | 28 | (11) | (27) | 34 | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (11) | (27) | 34 | |
Net income (loss): | 53 | 43 | 28 | (11) | (27) | 34 | ||
Other undisclosed net loss attributable to parent | (44) | (46) | (52) | (38) | (39) | (37) | ||
Net income (loss) available to common stockholders, diluted: | 8 | (3) | (24) | (49) | (65) | (2) |
Comprehensive Income ($ in millions)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 53 | 43 | 28 | (11) | (27) | 34 | ||
Other undisclosed comprehensive loss | (13) | |||||||
Comprehensive income (loss): | 53 | 43 | 15 | (11) | (27) | 34 | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (25) | 251 | (209) | (200) | (57) | |||
Comprehensive income (loss), net of tax, attributable to parent: | 53 | 18 | 266 | (220) | (227) | (23) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.